VIATRIS INC. Restructuring Reserve, Noncurrent
VIATRIS INC. (VTRS) had Restructuring Reserve, Noncurrent of $152.40 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:RestructuringReserveNoncurrent · last filed 2026-08-06
- 2026-06-30: Restructuring Reserve, Noncurrent $152.40M.
- 2026-03-31: Restructuring Reserve, Noncurrent $155.30M.
- 2025-12-31: Restructuring Reserve, Noncurrent $116.30M.
- 2025-09-30: Restructuring Reserve, Noncurrent $129.50M.
| Period end | Restructuring Reserve, Noncurrent |
|---|---|
| 2026-06-30 | $152.40M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $155.30M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $116.30M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $129.50M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $129.70M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $130.90M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $128.50M 10-K · filed 2026-02-26 |
| 2024-09-30 | $127.80M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $60.90M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $57.90M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $59.20M 10-K · filed 2025-02-27 |
| 2023-09-30 | $60.30M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $60.40M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $58.00M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $60.40M 10-K · filed 2024-02-28 |
| 2022-09-30 | $51.00M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $51.20M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $51.40M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $64.30M 10-K · filed 2023-02-27 |
| 2021-09-30 | $122.00M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $126.60M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $154.60M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $134.80M 10-K · filed 2022-02-28 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |